Brief: Amarin Receives Positive Recommendation From Spanish Drug Pricing Committee For National Reimbursement Of Heart Drug
25/07/2023 22:21
July 25 (Reuters) - Amarin Corporation PLC AMRN.O :
* AMARIN RECEIVES POSITIVE RECOMMENDATION FROM SPANISH DRUG
PRICING COMMITTEE FOR NATIONAL REIMBURSEMENT OF VAZKEPA®
(ICOSAPENT ETHYL) IN SPAIN
* AMARIN CORPORATION PLC - EXPECTS ELIGIBLE CARDIOVASCULAR
PATIENTS TO BE ABLE TO ACCESS VAZKEPA UNDER NATIONAL
REIMBURSEMENT AS OF SEPTEMBER 1
Source text for Eikon: ID:nGNXbvb4VK
Further company coverage: AMRN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amarin
See all newsAmarin Corporation PLC reports results for the quarter ended June 30 - Earnings Summary
Ireland's Amarin Q2 revenue falls on lower licensing payments
Amarin Corporation PLC expected to post a loss of 1 cent a share - Earnings Preview
US Supreme Court backs generic drugmaker in 'skinny label' patent case (updated)
US Supreme Court backs generic drugmaker in 'skinny label' patent case